Korean Journal of Acupuncture

  • 제41권4호
  • /
  • Pages.127-135
  • /
  • 2024
  • /
  • 2287-3368(pISSN)
  • /
  • 2287-3376(eISSN)
경락경혈학회 (Society for Meridian and Acupoint)
권호 표지
DOI QR코드

DOI QR Code

파킨슨병 마우스 모델의 선조체에서 침 치료의 단백질 발현 조절

Acupuncture Modulates Protein Expression in the Striatum of Parkinson's Disease Mouse Model

  • Chaeyoon Kim (Department of Meridian and Acupoint, College of Korean Medicine, Sang Ji University) ;
  • Eun-Jung Kim (Department of Biomedical Laboratory Science, Sangji University) ;
  • Sung-Hee Hwang (Department of Pharmaceutical Engineering, College of Health Sciences, Sangji University) ;
  • Sujung Yeo (Department of Meridian and Acupoint, College of Korean Medicine, Sang Ji University)
  • 투고 : 2024.10.22
  • 심사 : 2024.12.11
  • 발행 : 2024.12.27
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : Parkinson's disease (PD) is a neurodegenerative disease caused by the loss of dopamine neurons in the brain. Previous studies have shown that acupuncture can delay the progression of the disease in the early stages of PD. Based on the findings from these studies, we investigated the underlying mechanisms by examining alterations in protein expression within the striatum, which is the site of lesions associated with PD. Methods : PD animal models were fabricated using neurotoxic compounds such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and the animal models were divided into the control group (CTL), the MPTP group that received only MPTP treatment, the MPTP-A group that received MPTP and acupuncture treatment at LR3 and GB34, and the MPTP-NA group that received MPTP and acupuncture treatment on both sides of the hip joint. Results : Behavioral data obtained from the rotarod test showed that motor function, which was significantly impaired due to the induction of PD (p<0.005), demonstrated a statistically significant improvement following acupuncture treatment (p<0.05). To investigate the mechanism involved in these neuroprotective effects, we studied the protein expression changes in the striatum of PD mouse model. MPTP_A group showed significant changes in protein expression of Axin-1 (Axin1), Integrin beta-6 (Itgb6), Aryl hydrocarbon receptor (Ahr), and Legumain (Lgmn). In addition, KEGG pathway analysis showed that these proteins are involved in dopaminergic synapses, cytoskeleton in muscle cells, mTOR signaling pathway, and etc. Conclusions : These results suggest that acupuncture treatment is expected to be effective in treating PD by altering the protein expression levels of Axin1, Itgb6, Ahr, and Lgmn.

키워드

과제정보

This research was supported by Sangji University Research Fund 2023.

참고문헌

  1. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006 ; 5 : 525-35. https://doi.org/10.1016/S1474-4422(06)70471-9
  2. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003 ; 39 : 889-909. https://doi.org/10.1016/s0896-6273(03)00568-3
  3. Macedo-Lima M, Remage-Healey L. Dopamine modulation of motor and sensory cortical plasticity among vertebrates. Integr Comp Biol. 2021 ; 61 : 316-36. https://doi.org/10.1093/icb/icab019
  4. De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A, et al. Parkinson's disease: autoimmunity and neuroinflammation. Autoimmun Rev. 2016 ; 15 : 1005-11. https://doi.org/10.1016/j.autrev.2016.07.022
  5. Verharen JPH, Adan RAH, Vanderschuren LJMJ. Differential contributions of striatal dopamine D1 and D2 receptors to component processes of value-based decision making. Neuropsychopharmacology. 2019 ; 44 : 2195-204. https://doi.org/10.1038/s41386-019-0454-0
  6. Zeng BY, Salvage S, Jenner P. Current development of acupuncture research in Parkinson's disease. Int Rev Neurobiol. 2013 ; 111 : 141-58. https://doi.org/10.1016/B978-0-12-411545-3.00007-9
  7. Zhao Y, Zhang Z, Qin S, Fan W, Li W, Liu J, et al. Acupuncture for Parkinson's disease: efficacy evaluation and mechanisms in the Dopaminergic Neural Circuit. Neural Plast. 2021 ; 2021 : 9926445. https://doi.org/10.1155/2021/9926445
  8. Pereira CR, Machado J, Rodrigues J, de Oliveira NM, Criado MB, Greten HJ. Effectiveness of acupuncture in Parkinson's disease symptoms-a systematic review. Healthcare (Basel). 2022 ; 10. https://doi.org/10.3390/healthcare10112334
  9. Emborg ME. Nonhuman primate models of Parkinson's disease. ILAR J. 2007 ; 48 : 339-55. https://doi.org/10.1093/ilar.48.4.339
  10. Yang JL, Chen JS, Yang YF, Chen JC, Lin CH, Chang RS, et al. Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice. Brain behav immun. 2011 ; 25 : 1452-9. https://doi.org/10.1016/j.bbi.2011.05.012
  11. Guo Y, Bamunuarachchi G, Vaddadi K, Zhu Z, Gandikota C, Ahmed K, et al. Axin1: a novel scaffold protein joins the antiviral network of interferon. Mol Microbiol. 2022 ; 118 : 731-43. https://doi.org/10.1111/mmi.14995
  12. Wang W, Liu P, Lavrijsen M, Li S, Zhang R, van de Geer WS, et al. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines. Scientific Reports. 2021 ;11 : 7470. https://doi.org/10.1038/s41598-021-87091-4
  13. Peng Y, Xu Y, Zhang X, Deng S, Yuan Y, Luo X, et al. A novel protein AXIN1-295aa encoded by circAXIN1 activates the Wnt/β-catenin signaling pathway to promote gastric cancer progression. Mol Cancer. 2021 ; 20 : 158. https://doi.org/10.1186/s12943-021-01457-w
  14. Granados JC, Falah K, Koo I, Morgan EW, Perdew GH, Patterson AD, et al. AHR is a master regulator of diverse pathways in endogenous metabolism. Scientific Reports. 2022 ; 12 : 16625. https://doi.org/10.1038/s41598-022-20572-2
  15. Rothhammer V, Quintana FJ. The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. Nat Rev Immunol. 2019 ; 19 : 184-97. https://doi.org/10.1038/s41577-019-0125-8
  16. Solberg R, Lunde NN, Forbord KM, Okla M, Kassem M,JafariA. The mammalian cysteine protease legumain in health and disease. Int J Mol Sci. 2022 : 23. https://doi.org/10.3390/ijms232415983
  17. Khan SU, Khan IM, Khan MU, Ud Din MA, Khan MZ, Khan NM, et al. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment. Front Mol Biosci. 2023 ; 10 : 1121964. https://doi.org/10.3389/fmolb.2023.
  18. Zhang Z, Wang Z, Liu T, Tang J, Liu Y, Gou T, et al. Exploring the role of ITGB6: fibrosis, cancer, and other diseases. Apoptosis. 2024 ; 29 : 570-85. https://doi.org/10.1007/s10495-023-01921-6
  19. Krissansen GW, Yuan Q, Jenkins D, Jiang WM, Rooke L, Spurr NK, et al. Chromosomal locations of the genes coding for the integrin beta 6 and beta 7 subunits. Immunogenetics. 1992 ; 35 :58-61. https://doi.org/10.1007/BF00216629
  20. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGFbeta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999 ; 96 : 319-28. https://doi.org/10.1016/s0092-8674(00)80545-0
  21. Massagué J. TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012 ; 13 : 616-30. https://doi.org/10.1038/nrm3434
  22. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006 ; 24 : 99-146. https://doi.org/10.1146/annurev.immunol.24.021605.090737
  23. Cai B, Wang Q, Zhong L, Liu F, Wang X, Chen T. Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson's Disease. Drug Des Devel Ther. 2024 ; 18 : 2869-81. https://doi.org/10.2147/DDDT.S462333
  24. Hunn BH, Cragg SJ, Bolam JP, Spillantini MG, Wade-Martins R. Impaired intracellular trafficking defines early Parkinson's disease. Trends Neurosci. 2015 ; 38 : 178-88. https://doi.org/10.1016/j.tins.2014.12.009
  25. Lan AP, Chen J, Zhao Y, Chai Z, Hu Y. mTOR signaling in Parkinson's disease. Neuromolecular Med. 2017 ; 19 : 1-10. https://doi.org/10.1007/s12017-016-8417-7
  26. Wang X, Li N, Xiong N, You Q, Li J, Yu J, et al. Genetic variants of microtubule actin cross-linking factor 1 (MACF1) confer risk for Parkinson's disease. Molecular neurobiology. 2017 ; 54 :2878-88. https://doi.org/10.1007/s12035-016-9861-y